The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.
Neuroendocrine tumours have a particular tendency to express functional receptors and/or uptake mechanisms. Radionuclides, such as 123I-MIBG, which is taken up by a specific uptake mechanism, and 111In-pentetreotide, which binds to somatostatin receptors, present an imaging modality based on these p...
Main Authors: | Kaltsas, G, Mukherjee, J, Grossman, AB |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2001
|
Similar Items
-
Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
by: Kaltsas, G, et al.
Published: (2005) -
Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
by: Ur, E, et al.
Published: (1993) -
The role of chemotherapy in the nonsurgical management of malignant neuroendocrine tumours.
by: Kaltsas, G, et al.
Published: (2001) -
The role of chemotherapy management of malignant in the nonsurgical neuroendocrine tumours
by: Kaltsas, G, et al.
Published: (2001) -
Familial paraganglioma: a novel presentation of a case and response to therapy with radiolabelled MIBG.
by: Lawrence, J, et al.
Published: (2004)